PRESICA

Welcome to the Brand page for “PRESICA”, which is offered here for Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, systemic lupus erythematosus, rh hemolytic disease of the newborn, antiphospholipid antibody syndrome, grave's disease, myasthenia gravis, hashimoto's thyroiditis, pemphigus, autoimmune hemolytic anemia, autoimmune thrombocytopenia purpura, antibody mediated infertility, sjogre's syndrome, mixed connective tissue disease, glomerulonephritis and goodpasture's syndrome;.

Its status is currently believed to be active. Its class is unavailable. “PRESICA” is believed to be currently owned by “LA JOLLA PHARMACEUTICAL COMPANY”.


Owner:
LA JOLLA PHARMACEUTICAL COMPANY
Owner Details
Description:
Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, systemic lupus erythematosus, RH hemolytic disease of the newborn, antiphospholipid antibody syndrome, Grave's disease, myasthenia gravis, Hashimoto's thyroiditis, pemphigus, autoimmune hemolytic anemia, autoimmune thrombocytopenia purpura, antibody mediated infertility, Sjogre's syndrome, mixed connective tissue disease, glomerulonephritis and Goodpasture's syndrome;
Categories: PHARMACEUTICAL PREPARATIONS PREVENTION OR